-
公开(公告)号:US20200060971A1
公开(公告)日:2020-02-27
申请号:US16679536
申请日:2019-11-11
申请人: CureVac AG
发明人: Fabian Johannes EBER , Benyamin YAZDAN PANAH , Stefanie SEWING , Thomas KETTERER , Thorsten MUTZKE , Tilmann ROOS , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K9/16 , A61P31/00 , A61P31/12 , A61P37/06 , A61P37/08 , A61P31/04 , A61P33/02 , A61P35/00 , A61K39/145 , A61K48/00
摘要: The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
-
公开(公告)号:US20220168225A1
公开(公告)日:2022-06-02
申请号:US17676586
申请日:2022-02-21
申请人: CureVac AG
发明人: Fabian Johannes EBER , Benyamin YAZDAN PANAH , Stefanie SEWING , Thomas KETTERER , Thorsten MUTZKE , Tilmann ROOS , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K9/16 , A61K48/00 , A61K9/19 , A61K31/7105
摘要: The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-freeze drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
-
公开(公告)号:US20190100784A1
公开(公告)日:2019-04-04
申请号:US16081863
申请日:2017-03-03
申请人: CureVac AG
IPC分类号: C12P19/34 , C12Q1/6806 , C12Q1/6809 , C12N9/22
摘要: The present invention relates to analysis of an RNA molecule. It further relates to the use of this method for the quality control of an RNA molecule produced by in vitro transcription or for the quality control of an RNA molecule produced by chemical synthesis.
-
公开(公告)号:US20180147146A1
公开(公告)日:2018-05-31
申请号:US15575284
申请日:2016-05-20
申请人: CureVac AG
发明人: Fabian Johannes EBER , Benyamin YAZDAN PANAH , Stefanie SEWIG , Thomas KETTERER , Thorsten MUTZKE , Tilmann ROOS , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K9/16 , A61K39/145 , A61P31/00 , A61P35/00 , A61P31/12 , A61P31/04 , A61P33/02 , A61P37/06 , A61P37/08
CPC分类号: A61K9/16 , A61K9/1682 , A61K39/145 , A61K48/00 , A61K48/005 , A61K48/0091 , A61K2039/53 , A61P31/00 , A61P31/04 , A61P31/12 , A61P33/02 , A61P35/00 , A61P37/06 , A61P37/08
摘要: The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
-
公开(公告)号:US20220387320A1
公开(公告)日:2022-12-08
申请号:US17811808
申请日:2022-07-11
申请人: CureVac AG
发明人: Fabian Johannes EBER , Benyamin YAZDAN PANAH , Stefanie SEWING , Thomas KETTERER , Thorsten MUTZKE , Tilmann ROOS , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K9/16 , A61K48/00 , A61P31/00 , A61P31/12 , A61P37/06 , A61P37/08 , A61P31/04 , A61P33/02 , A61P35/00 , A61K39/145
摘要: The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
-
公开(公告)号:US20210180106A1
公开(公告)日:2021-06-17
申请号:US16077366
申请日:2016-02-12
申请人: CureVac AG
IPC分类号: C12Q1/6806
摘要: The present invention relates to the field of RNA analysis. In particular, the invention concerns the use of one or more nucleic acid molecules for the analysis of an RNA molecule. In particular, the method is suitable for use in quality control during or following production of RNA. Furthermore, the present invention provides methods for analyzing a mixture of RNA molecules or an RNA population.
-
公开(公告)号:US20200040370A1
公开(公告)日:2020-02-06
申请号:US16658700
申请日:2019-10-21
申请人: CureVac AG
IPC分类号: C12P19/34 , C12Q1/6865 , C12N15/52
摘要: The present invention is concerned with a method of producing a target RNA using a circular DNA, wherein said method does not comprise a step of linearizing said circular DNA. The present invention further relates to a circular DNA comprising an RNA polymerase promoter sequence, followed by a sequence encoding a target RNA, followed by a sequence encoding a self-cleaving ribozyme, followed by an RNA polymerase terminator sequence element, wherein the latter element may comprise several RNA polymerase terminator sequences. Multimeric DNA obtained by rolling circle amplification of said circular DNA is also within the scope of the present invention.
-
公开(公告)号:US20190133950A1
公开(公告)日:2019-05-09
申请号:US15575301
申请日:2016-05-20
申请人: CureVac AG
发明人: Fabian Johannes EBER , Benyamin YAZDAN PANAH , Stefanie SEWIG , Thomas KETTERER , Thorsten MUTZKE , Tilmann ROOS , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K9/16 , A61K31/7105 , A61K9/19
摘要: The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-freeze drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
-
公开(公告)号:US20190017100A1
公开(公告)日:2019-01-17
申请号:US15738641
申请日:2016-07-01
申请人: CureVac AG
IPC分类号: C12Q1/6811 , C12Q1/6806 , C12Q1/6809 , C12N15/11
摘要: The present invention relates to the field of RNA analysis. In particular, the invention concerns the use of a catalytic nucleic acid molecule for the analysis of an RNA molecule and/or of a population of RNA molecules. In one aspect, the invention concerns methods for analyzing RNA molecules having at least one cleavage site for at least one catalytic nucleic acid molecule. In particular, the invention concerns a method for determining a physical property of an RNA molecule by analyzing a 5′ terminal fragment, a 3′ terminal fragment and/or at least one optional central RNA fragment obtained by cleavage of the RNA molecule by at least one catalytic nucleic acid molecule. Moreover, the present invention provides novel uses of a catalytic nucleic acid molecule for analyzing RNA molecules. In particular, the invention relates to the use of a catalytic nucleic acid molecule in a method for analyzing RNA molecules, wherein the resulting 5′ terminal RNA fragment, the 3′ terminal RNA fragment and/or the at least one optional central RNA fragment are analyzed.
-
公开(公告)号:US20180214537A1
公开(公告)日:2018-08-02
申请号:US15566010
申请日:2016-04-13
申请人: CureVac AG
发明人: Thorsten MUTZKE , Markus KREUZ , Stefanie SEWING , Fabian Johannes EBER , Wenke WAGNER , Michael SONNTAG , Michael WIGGENHORN , Katharina KOLLAND
IPC分类号: A61K39/145
CPC分类号: A61K39/145 , A61K9/5169 , A61K9/5192 , A61K39/12 , A61K47/6455 , A61K47/646 , A61K2039/55555 , C12N2760/16134
摘要: The present invention relates to a method for producing a liquid composition comprising a nanoparticle comprising at least one RNA and at least one cationic or polycationic compound, advantageously on a large scale suitable for pharmaceutical applications. The present invention further concerns the use of the inventive method in the manufacture of a medicament or a vaccine. Furthermore, the invention relates to compositions containing the RNA-comprising nanoparticle, and to pharmaceutical compositions comprising the same.
-
-
-
-
-
-
-
-
-